Stock Scorecard

Stock Summary for Ascendis Pharma A/S (ASND) - $230.70 as of 9/25/2026 12:10:52 PM EST

Total Score

14 out of 30

Safety Score

70 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for ASND

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ASND

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ASND

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ASND

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ASND (70 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 8
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for ASND

Company Overview
Ticker ASND
Company Name Ascendis Pharma A/S
Country USA
Description Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 6/30/2026
Next Earnings Date 11/11/2026

Stock Price History
Last Day Price 230.70
Price 4 Years Ago 122.13
Last Day Price Updated 9/25/2026 12:10:52 PM EST
Last Day Volume 1,165,643
Average Daily Volume 727,982
52-Week High 282.15
52-Week Low 186.05
Last Price to 52 Week Low 24.00%

Valuation Measures
Trailing PE 17.36
Industry PE 27.95
Sector PE 63.75
5-Year Average PE -4.88
Free Cash Flow Ratio 18.70
Industry Free Cash Flow Ratio 35.85
Sector Free Cash Flow Ratio 33.68
Current Ratio Most Recent Quarter 2.99
Total Cash Per Share 12.34
Book Value Per Share Most Recent Quarter 25.08
Price to Book Ratio 9.48
Industry Price to Book Ratio 12.84
Sector Price to Book Ratio 9.79
Price to Sales Ratio Twelve Trailing Months 14.02
Industry Price to Sales Ratio Twelve Trailing Months 58.19
Sector Price to Sales Ratio Twelve Trailing Months 41.16
Analyst Buy Ratings 16
Analyst Strong Buy Ratings 4

Share Statistics
Total Shares Outstanding 65,783,000
Market Capitalization 15,176,138,100
Institutional Ownership 104.02%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 42.07%
Reported EPS 12 Trailing Months 12.85
Reported EPS Past Year 3.56
Reported EPS Prior Year -4.06
Net Income Twelve Trailing Months 755,848,813
Net Income Past Year -219,034,140
Net Income Prior Year -378,084,000
Quarterly Revenue Growth YOY 114.70%
5-Year Revenue Growth 150.93%
Operating Margin Twelve Trailing Months 65.00%

Balance Sheet
Total Cash Most Recent Quarter 811,924,690
Total Cash Past Year 615,778,613
Total Cash Prior Year 559,543,000
Net Cash Position Most Recent Quarter 427,282,690
Net Cash Position Past Year 230,524,613
Long Term Debt Past Year 385,254,000
Long Term Debt Prior Year 365,080,000
Total Debt Most Recent Quarter 384,642,000
Equity to Debt Ratio Past Year -0.73
Equity to Debt Ratio Most Recent Quarter 0.79
Total Stockholder Equity Past Year -162,751,650
Total Stockholder Equity Prior Year -105,706,000
Total Stockholder Equity Most Recent Quarter 1,435,898,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 336,895,595
Free Cash Flow Per Share Twelve Trailing Months 5.12
Free Cash Flow Past Year 43,619,717
Free Cash Flow Prior Year -307,624,000

Options
Put/Call Ratio 0.88
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.04
MACD Signal 2.74
20-Day Bollinger Lower Band 204.97
20-Day Bollinger Middle Band 239.89
20-Day Bollinger Upper Band 274.81
Beta 0.48
RSI 41.05
50-Day SMA 0.00
150-Day SMA 166.21
200-Day SMA 150.30

System
Modified 9/24/2026 5:41:22 PM EST